The Clinical Effect of Normal Diet and Absolute Diet on Post-polypectomy Patients: an Open-label, Randomized Controlled Trial

There is no evidence to prove the impact of post-procedural diet on post-polypectomy bleeding (PPB) or delayed perforation. No relevant study has been conducted and it is yet to be determined if absolute diet is necessary for post-polypectomy patients, and the comparison between normal diet and absolute diet also remains unclear. Therefore, we carried out this randomized controlled study to evaluate and compare tthe clinical effect of different diets on post-polypectomy patients.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

406

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. 18-75 patient with initial diagnosis of colorectal polyp by colonoscopy;
  2. The maximum size of polyp is more than 20mm;
  3. The patients underwent single ESD procedure for the polyp and agreed to participate this trial.

Exclusion Criteria:

  1. Uncontrollable hypertension or diabetes;
  2. Severe comorbidities such as cancer and organ failure etc;
  3. Patients who were pregnant;
  4. Patients had anticoagulants during perioperative period;
  5. Patients with poor compliance. -

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Absolute diet
Patients in absolute diet group were fasted from any food with intravenous infusion of 5% glucose and sodium chloride instead in the first 24 hours. Then, the patients will be given soup for the next 24 hours if there was no delayed complication or discomfort during the fasting. Finally, they will gradually transit from soup to normal diet such as porridge, noodles and rice in the third 24 hours.
Experimental: Normal diet
Patients in normal diet group were directly given normal diet such as porridge, noodles and rice as usual after polypectomy. Meanwhile, all the patients in two groups were given PPI for 3 days intravenously and restricted from vigorous exercise for 14 days.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
postoperative adverse event rate
Time Frame: 14-day after polypectomy
Postoperative AE includes PPB, post polypectomy electrocoagulation syndrome(PPES) and delayed perforation.
14-day after polypectomy

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
length of stay
Time Frame: 14-day after polypectomy
calculated by subtracting day of admission from day of discharge.
14-day after polypectomy
hospitalization cost
Time Frame: 14-day after polypectomy
represent the hospital's costs of patients at the hospital
14-day after polypectomy

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

June 15, 2019

Primary Completion (Anticipated)

June 15, 2021

Study Completion (Anticipated)

July 20, 2021

Study Registration Dates

First Submitted

June 9, 2019

First Submitted That Met QC Criteria

June 16, 2019

First Posted (Actual)

June 18, 2019

Study Record Updates

Last Update Posted (Actual)

June 18, 2019

Last Update Submitted That Met QC Criteria

June 16, 2019

Last Verified

June 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • NFEC-2017-080

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Polyp Colorectal

Clinical Trials on absolute diet

Subscribe